Peroxiredoxin 1 Monoclonal Antibody

Mouse Anti-Peroxiredoxin 1 Monoclonal Antibody

Product Specifications

Background

PRDX1 encodes a member of the peroxiredoxin family of antioxidant enzymes, which reduce hydrogen peroxide and alkyl hydroperoxides. Peroxiredoxin 1 may play an antioxidant protective role in cells, and may contribute to the antiviral activity of CD8 (+) T-cells. Peroxiredoxin 1 may have a proliferative effect and play a role in cancer development or progression. Four transcript variants encoding the same protein have been identified for PRDX1.

Product Name Alternative

PRDX1; PAGA; PAGB; TDPX2; Peroxiredoxin-1; Natural killer cell-enhancing factor A; NKEF-A; Proliferation-associated gene protein; PAG; Thioredoxin peroxidase 2; Thioredoxin-dependent peroxide reductase 2

Gene ID

5052

Accession Number

Q06830

Reactivity

Human, Mouse, Rat

Immunogen

Recombinant Protein

Clonality

Monoclonal

Tag

Peroxiredoxin-1

Applications

WB, IHC, IF

Purification Method

The antibody was affinity-purified from mouse ascites by affinity-chromatography using specific immunogen.

Concentration

1 mg/ml

Molecular Weight

21kD

Precautions

The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Shipping Conditions

Gel pack with blue ice.

Storage Conditions

Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.

Notes

The antibody detects endogenous Peroxiredoxin 1 protein.

Formulation

Liquid solution

Buffer pH

PBS, pH 7.4, containing 0.5%BSA, 0.02% sodium azide as Preservative and 50% Glycerol.

Applications Notes

Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:1000-3000; IF 1:100-200; IHC 1:50-300